VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 128 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 7.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $34,000 | -12.8% | 2,085 | -28.9% | 0.00% | – |
| Q3 2019 | $39,000 | -25.0% | 2,931 | -21.0% | 0.00% | – |
| Q2 2019 | $52,000 | -23.5% | 3,712 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $68,000 | -11.7% | 3,712 | +27.3% | 0.00% | 0.0% |
| Q4 2018 | $77,000 | +92.5% | 2,916 | +66.2% | 0.00% | – |
| Q3 2018 | $40,000 | +21.2% | 1,755 | 0.0% | 0.00% | – |
| Q2 2018 | $33,000 | +10.0% | 1,755 | 0.0% | 0.00% | – |
| Q1 2018 | $30,000 | +11.1% | 1,755 | 0.0% | 0.00% | – |
| Q4 2017 | $27,000 | -12.9% | 1,755 | 0.0% | 0.00% | – |
| Q3 2017 | $31,000 | +6.9% | 1,755 | 0.0% | 0.00% | -100.0% |
| Q2 2017 | $29,000 | +16.0% | 1,755 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $25,000 | – | 1,755 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |